William J. Keephart CPA PA specializes in small to medium-sized businesses and individuals, Prager Metis said.

“With all due respect, we cannot have communities mirroring the cavalier actions taken in other states that have not put a premium on … the health of their residents,” the governor said in response to the city's ordinance, which would have permitted service indoors, at reduced capacity, beginning June 15.

While the state’s unemployment rate is at a historically high 15.3 percent, according to data released Thursday new jobless claims have dropped considerably.

The company is only the 11th to launch an alternative treatment center statewide, and just one of three licensed to serve South Jersey.

At a June 9 webinar hosted by the New Jersey Chamber of Commerce and the New Jersey Business & Industry Association, Senate President Stephen Sweeney asked “Why would I open up my business if I’m going to open up to being sued?” Meanwhile, that same day at a press briefing, Gov. Phil Murphy described the concern as "an understandable one, given ... the extraordinary environment that we're in."

The insurer kicked off the week by promoting two of its own to executive positions, now it’s bringing a leader with more than 20 years of experience onto its team.

Jeff Fazio will lead a team of approximately 100 employees focusing on companies with revenues of $1 million and under in the newly created position.

Under the terms of a June 11 agreement, the board of directors will be reconstituted to be comprised of nine directors—eight picks from the investment firm and one nominated by the REIT.

The 25,437-square-foot Caroline and Frank Guarini Sr. Performing Arts Center is set to serve as a cornerstone to the school's $400 million redevelopment project, University Place.

Located in the heart of Mercer County, the complex is approximately 65 percent occupied with a mix of national and international companies.

The company plans to list on the New York Stock Exchange under the symbol DNB.

The transaction is expected to close in the third quarter of 2020, at which time DelMar is expected to change its name to Kintara Therapeutics Inc. and trade on Nasdaq,